RUBICON RESEARCH LIMITED vs ZYDUS LIFESCIENCES LTD

A side-by-side comparison of RUBICON RESEARCH LIMITED (RUBICON) and ZYDUS LIFESCIENCES LTD (ZYDUSLIFE) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, ZYDUS LIFESCIENCES LTD leads RUBICON vs ZYDUSLIFE on 8 of 14 metrics (1 tied). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

96.29
P/E ratio
22.83
18.04
P/B ratio
4.09
0.11%
Dividend yield
0.09%
₹14.95
EPS
₹50.09

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

27.00%
Return on equity
21.20%
28.00%
Return on capital
21.00%
23.00%
EBITDA margin
31.00%
14.08%
Net margin
18.87%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

64.50%
Revenue CAGR (3Y)
16.35%
Profit CAGR (3Y)
34.80%

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹23,699 Cr
Market cap
₹1.15L Cr
₹1,754 Cr
Revenue
₹27,148 Cr
₹247 Cr
Net profit
₹5,124 Cr
0.24
Debt / equity
0.46
RUBICON RESEARCH LIMITED
  • + ["Company has reduced debt.", "Company has delivered good profit growth of 52.0% CAGR over last 5 years", "Company has a good return on equity (ROE) track record: 3 Years ROE 27.5%"]
  • ["Stock is trading at 18.3 times its book value", "Working capital days have increased from 68.8 days to 104 days"]
ZYDUS LIFESCIENCES LTD
  • + ["Company has delivered good profit growth of 18.8% CAGR over last 5 years"]
RUBICON RESEARCH LIMITED full analysis ZYDUS LIFESCIENCES LTD full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.